Home / Companies / Takeda Pharmaceutical Co., Ltd. / 25 Jun 2025
Takeda Pharmaceutical Co., Ltd.: meeting of 25 Jun 2025
Votes reported on Form N-PX, item by item
156 Form N-PX filers reported votes at the Takeda Pharmaceutical Co., Ltd. meeting of 25 Jun 2025. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
10 nominees; 90.2% of reported votes for; 107 filers withheld from or voted against at least one nominee.
3,014 vote records from 156 filers. 2 of the 156 filers that marked the item either way voted against management.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
37 vote records from 19 filers. 13 of the 19 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
305 vote records from 156 filers. 0 of the 156 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
265 vote records from 137 filers. 101 of the 137 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
37 vote records from 10 filers. 0 of the 1 filers that marked the item either way voted against management. 9 filers reported this item without a management mark.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
31 vote records from 15 filers. No filer marked a management recommendation, so no against-management figure is reported. 15 filers reported this item without a management mark.
How the largest families voted
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Takeda Pharmaceutical Co., Ltd. meeting?
156 Form N-PX filers reported votes at the meeting of 25 Jun 2025. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Takeda Pharmaceutical Co., Ltd. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Takeda Pharmaceutical Co., Ltd.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Takeda Pharmaceutical Co., Ltd. with a meeting date within three days of 25 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.